Early Ebola Treatment Trials Show Promise Against Deadly Congo Outbreak – Yahoo News Canada
Early Ebola Treatment Trials Show Promise Against Deadly Congo Outbreak Yahoo News CanadaDR Congo Ebola outbreak kills more than…
Fixed-dose inotuzumab ozogamicin (INO) combined with Vincristine and Prednisone (VP) regimen as induction therapy for newly diagnosed B-cell acute lymphocytic leukemia (B-ALL): a multi-center, open-label, single-arm, prospective clinical study
Adult B-ALL exhibits significant heterogeneity and poor prognosis compared with the pediatric population. While the complete remission (CR)…
Opinion | The Peptide Wild West
One of the more successful activist campaigns in U.S. history was about keeping dietary supplements virtually unregulated. In…
Are Omega-3 Supplements Actually Good for Your Brain?
In theory, taking an omega-3, or fish oil, supplement makes a lot of sense. Omega-3 fatty acids are…
TG Therapeutics Announces Initiation of Phase 2 Trial Evaluating BRIUMVI in Patients with Treatment-Resistant Schizophrenia
TG Therapeutics, Inc. Phase 2 trial to evaluate the effects of B-cell depletion with BRIUMVI in approximately 60…
Definium LSD therapy for major depression helped patients in Phase 3 trial
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected…
Eledon Presents Long-Term Extension Phase 2 BESTOW Results at American Transplant Congress Showing Sustained Higher Kidney Function and Improved Patient-Reported Outcomes with Tegoprubart Compared with Tacrolimus
Eledon Pharmaceuticals, Inc. Tegoprubart-treated patients maintained higher mean eGFR over time, including a statistically significant approximately 12 mL/min/1.73…
Fish oil supplements may not prevent Alzheimer’s-related decline
LOS ANGELES — Americans spend more than $1 billion annually on fish oil supplements, in part due to purported cognitive…
TG Therapeutics Announces Positive Topline Phase 1 Data for Subcutaneous BRIUMVI in Patients with Myasthenia Gravis and Initiation of Potential Registration Directed Randomized Phase 2 Trial
TG Therapeutics, Inc. 82% of subjects achieved an MCID in their MG-ADL with a mean >4 point improvement…
AI-designed ‘universal vaccine’ candidate passes first human trial
Image: © Bill Oxford | iStock An innovative universal vaccine technology has successfully completed its first human clinical…
The Supplement That Science Says Could Make the World Less Angry
If you found out a supplement existed that could lower aggression, you would probably think it was something…
Industry and regulators signal a smarter, collaborative era for supplement oversight
While the industry has spent years bracing for and fending off a heavier regulatory hand, what it heard…